Cimoxatone
From Wikipedia, the free encyclopedia
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
3-[[4-[5-(methoxymethyl)-2-oxo-oxazolidin-3-yl]phenoxy]methyl]benzonitrile
|
|
| Identifiers | |
| CAS Number | 73815-11-9  |
| ATC code | none |
| PubChem | CID 52542 |
| ChemSpider | 47493 |
| UNII | V6FT1QJ7VL |
| KEGG | D02581 |
| ChEMBL | CHEMBL2104092  |
| Chemical data | |
| Formula | C19H18N2O4 |
| Molar mass | 338.36 g/mol |
|
|
| (what is this?) (verify) |
|
Cimoxatone (MD 780515) is a reversible inhibitor of MAO-A (RIMA).[1] It has a significant food interaction–related adverse effect in combination with tyramine.[2] It was never marketed.
See also[edit]
References[edit]
- ^ Nair NP, Ahmed SK, Kin NM, West TE (1995). "Reversible and selective inhibitors of monoamine oxidase A in the treatment of depressed elderly patients". Acta Psychiatr Scand Suppl. 386: 28–35. doi:10.1111/j.1600-0447.1995.tb05921.x. PMID 7717092.
- ^ Nair NP, Ahmed SK, Kin NM (November 1993). "Biochemistry and pharmacology of reversible inhibitors of MAO-A agents: focus on moclobemide". J Psychiatry Neurosci. 18 (5): 214–25. PMC 1188542
. PMID 7905288.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
